Molecular Pathology is an emerging discipline within pathology which is focussed in the study and diagnosis of disease through the examination of molecules within organs, tissues or body fluids. The samples which are studied primarily come from NHS patients.
Using a range of new scientific techniques it has been shown that many diseases are much more diverse than originally thought. With each patient demonstrating a different number or combination of gene alterations, patient to patient differences can have a marked influence on the diagnosis and prognosis of the patient.
This has led to the concept of “stratified” medicine in which treatment is adjusted to meet the needs of individual patients. This approach ensures that the right treatment is given to the right patient at the right time. Using this approach, only medicines that are likely result in positive patient outcomes, with limited side effects, can be provided, presenting both clinical and economic benefits, by avoiding unnecessary toxicity and conserving expensive new therapies.